Solid Biosciences Inc (SLDB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,122 | 80,235 | 74,015 | 155,384 | 119,136 |
| Marketable Securities | 127,950 | 68,685 | 49,625 | 58,338 | 88,643 |
| Receivables | N/A | N/A | N/A | N/A | 110 |
| TOTAL | $205,456 | $157,302 | $129,734 | $219,638 | $222,612 |
| Non-Current Assets | |||||
| PPE Net | 4,169 | 4,747 | 6,624 | 9,657 | 6,462 |
| Other Non-Current Assets | 22,915 | 26,613 | 28,581 | 30,957 | 3,306 |
| TOTAL | $27,084 | $31,360 | $35,205 | $40,614 | $9,768 |
| Total Assets | $232,540 | $188,662 | $164,939 | $260,252 | $232,380 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,224 | 4,237 | 2,032 | 3,238 | 4,463 |
| Accrued Expenses | 18,945 | 19,852 | 10,161 | 16,691 | 9,528 |
| Other current liabilities | 9,200 | 3,150 | N/A | 14 | 35 |
| TOTAL | $33,472 | $30,257 | $14,517 | $22,508 | $23,601 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 8,080 |
| Other Non-Current Liabilities | 19,058 | 21,159 | 22,707 | 24,375 | 275 |
| TOTAL | $19,058 | $21,159 | $23,941 | $26,078 | $568 |
| Total Liabilities | $52,530 | $51,416 | $38,458 | $48,586 | $24,169 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 98,391 | 77,493 | 37,757 | 19,573 | 7,369 |
| Common Shares | 79 | 40 | 20 | 20 | 7 |
| Retained earnings | -957,775 | -783,450 | -658,753 | -562,738 | -476,757 |
| Other shareholders' equity | 52 | 47 | 15 | -68 | -45 |
| TOTAL | $180,010 | $137,246 | $126,481 | $211,666 | $208,211 |
| Total Liabilities And Equity | $232,540 | $188,662 | $164,939 | $260,252 | $232,380 |